Lactation Support Supplements Market Size, Growth, Trends | Report 2023-2032
The global lactation support supplements market was valued at USD 569.84 million in 2022 and it is predicted to surpass around USD 1,085.85 million by 2032 with a CAGR of 6.66% from 2023 to 2032.
Key Pointers
Report Scope of the Lactation Support Supplements Market
| Report Coverage | Details |
| Market Size in 2022 | USD 569.84 million |
| Revenue Forecast by 2032 | USD 1,085.85 million |
| Growth rate from 2023 to 2032 | CAGR of 6.66% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Pink Stork; New Chapter; Mama's Select; ACTIF USA; Anya; Mommy’s Bliss Inc.; Nestle; Mother Love; Mommy Knows Best; Rumina Naturals |
The growth can be attributed to the increasing infant mortality rates due to rising cases of undernutrition owing to insufficient milk supply in the early days of childbirth. Insufficient breastfeeding is one of the major reasons for the higher infant mortality rate globally. According to UNICEF data, the neonatal mortality rate in 2021 was around 18 deaths per 1,000 live births globally.
The prevalence of human milk insufficiency is growing globally, which has increased the adoption of lactation supplements and formulas to promote human milk production. According to the article published in the Lancet Journal in February 2023, around 50% of the mothers who self-report insufficient milk have adopted commercial milk formulas in the first few months and are prematurely stopping breastfeeding. This is expected to boost the demand in the market over the forecast period.
The COVID-19 pandemic negatively impacted the industry's growth in the early phase owing to the mental and physical challenges due to the restrictions led by the pandemic. Moreover, the disruptions in the supply chain decreased the demand for these products in the initial phase. The breastfeeding rates significantly decreased during the pandemic owing to the isolation norms for COVID-19 patients. According to the article published in Mary Ann Liebert, Inc. in January 2022, in Los Angeles County, U.S., infants born in March 2020 reported decreased breastfeeding at one month, around 76.96%, compared to infants born before March 2020, which is around 79.66%.
The companies in the lactation support supplements industry are adopting several strategies, including launching innovative products with different ingredients, to gain a competitive advantage. For instance, in January 2022, Motfi Medical expanded its lactation support supplements product line with the launch of gluten- and fenugreek-free breastfeeding supplements. The two products are Enhanced Milk Nutrition Support and Milk Boosting Support, which aids breast milk production and enhances milk flow.
Ingredient Type Insights
The fenugreek segment held the largest revenue share of 28.76% in 2022. This can be attributed to the benefits associated with fenugreek with no or minimal side effects and the availability of the number of products containing fenugreek as an ingredient. Fenugreek seeds are traditionally used in the Middle East, the Indian subcontinent, and China as a condiment and to enhance the milk supply in lactating women. It is now increasingly adopted in the Western region for various ailments, including enhancing lactation in breastfeeding mothers.
However, the oatmeal segment is expected to witness the fastest growth over the forecast period. The high growth rate of the segment could be attributed to the benefits associated with oatmeal products in lactation. Hence, many companies are launching several products, including oatmeal cookies that do not have a pungent taste and smell as that of other herbal lactating supplements, which is expected to boost the demand for these products over the forecast period. Moreover, organizations such as the U.S. Department of Health and Human Services recommend oatmeal as a whole grain for breastfeeding women.
Formulation Insights
The capsules/tablets segment dominated the industry with a revenue share of 52.47% in 2022. Most of the galactagogues are available as capsules or tablets as it masks the pungent smell and taste of the herbal ingredients. Furthermore, these formulations are made with a precise dose that could be administered by breastfeeding women to get better results and reduce the chances of overdose and side effects associated with it. These factors are expected to contribute to the large share of the market.
The liquid segment is expected to grow at the fastest CAGR over the forecast period owing to the launch of several liquid formulations and the availability of many flavored products to mask the taste and smell of the ingredients. These products are easy to administer and have high concentrations of active ingredients that aid in boosting the milk supply in lactating women.
Sales Channel Insights
The direct sales channel segment dominated the market with 34.06% of the revenue share in 2022. This can be attributed to the higher preference of the customers to buy these products through direct sales channels. These products are intended for medicinal purposes and have herbal content and yet do not have any stringent regulations. This is expected to contribute to the growth of the segment.
However, the online sales segment is expected to grow with the fastest CAGR over the forecast period. The growing availability of these products at e-commerce platforms and the convenience of choosing the product from a wide range of portfolios that fulfills the demand of the customer are expected to drive the growth of the market during the forecast period. The online sales channel offers a wide range of products at a discounted price and reduces the efforts to travel to the onsite store.
Regional Insights
Asia Pacific held the largest revenue share of 38.75% as of 2022. The availability of lactation support supplements and the high adoption of these supplements traditionally contribute to the high share of the market in the region. According to the research article published in the PLOS ONE Journal in July 2021, around 60% of breastfeeding mothers in Australia reported the use of one or more galactagogues. Around 47% of them reported the use of lactation cookies, 32% reported the use of brewer’s yeast, and around 22% reported the use of fenugreek.
The MEA region is projected to witness the fastest CAGR over the forecast period. The rising prevalence of milk supply insufficiency and increased infant mortality rate in the region is expected to contribute to the growth during the forecast period. According to World Bank data, the infant mortality rate in South Africa in 2021 was around 26 per 1,000 live births. This is majorly due to the undernutrition and low breastfeeding rates in the country.
Lactation Support Supplements Market Segmentations:
By Ingredient Type
By Formulation
By Sales Channel
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Ingredient Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Lactation Support Supplements Market
5.1. COVID-19 Landscape: Lactation Support Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Lactation Support Supplements Market, By Ingredient Type
8.1. Lactation Support Supplements Market, by Ingredient Type, 2023-2032
8.1.1 Fenugreek
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Moringa
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Milk thistle
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Fennel
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Oatmeal
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Lactation Support Supplements Market, By Formulation
9.1. Lactation Support Supplements Market, by Formulation, 2023-2032
9.1.1. Capsules/Tablets
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Powder
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Liquid
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Lactation Support Supplements Market, By Sales Channel
10.1. Lactation Support Supplements Market, by Sales Channel, 2023-2032
10.1.1. Online Sales Channel
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Direct Sales Channel
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Pharmacies/Drug Stores
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Other Offline Channels
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Lactation Support Supplements Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.1.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.2.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.3.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Ingredient Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Formulation (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Sales Channel (2020-2032)
Chapter 12. Company Profiles
12.1. Pink Stork
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. New Chapter
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Affirm, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Mama's Select
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ACTIF USA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Anya
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Mommy’s Bliss Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Mother Love
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Mommy Knows Best
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers